The regulation of exosome secretion: a novel function of the p53 protein.

The p53 protein responds to stress signals by regulating the transcription of a variety of genes. Some of these genes encode secreted proteins that may be involved in the communication between adjacent cells. In this study, a proteomics approach was employed to identify proteins secreted by cells in a p53-dependent manner after DNA damage. In addition to the known transcriptional targets of p53, a set of proteins encoded by genes that are not transcriptional targets of p53 were found to increase in the culture medium after p53 activation. These proteins exit the cell via small, secreted vesicles called exosomes and exosome production by cells was found to be regulated by the p53 response. A p53-regulated gene product, TSAP6, was shown to enhance exosome production in cells undergoing a p53 response to stress. Thus, the p53 pathway regulates the production of exosomes into the medium and these vesicles can communicate with adjacent cells and even cells of the immune system.

[1]  Laurence Zitvogel,et al.  Molecular Characterization of Dendritic Cell-Derived Exosomes , 1999, The Journal of cell biology.

[2]  Rong-Fong Shen,et al.  Identification and proteomic profiling of exosomes in human urine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  N. Blom,et al.  Feature-based prediction of non-classical and leaderless protein secretion. , 2004, Protein engineering, design & selection : PEDS.

[4]  J. Little,et al.  Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. , 1998, Radiation research.

[5]  J. Little,et al.  The radiation-induced bystander effect: evidence and significance , 2004, Human & experimental toxicology.

[6]  A. Levine,et al.  p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. , 1991, Genes & development.

[7]  S. Sheng,et al.  mMaspin: The Mouse Homolog of a Human Tumor Suppressor Gene Inhibits Mammary Tumor Invasion and Motility , 1997, Molecular medicine.

[8]  E. Appella,et al.  p53 Regulates the Expression of the Tumor Suppressor Gene Maspin* , 2000, The Journal of Biological Chemistry.

[9]  B. Goud,et al.  TSAP6 Facilitates the Secretion of Translationally Controlled Tumor Protein/Histamine-releasing Factor via a Nonclassical Pathway* , 2004, Journal of Biological Chemistry.

[10]  P. Seth,et al.  Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53 , 1997, Gene Therapy.

[11]  C. Mothersill,et al.  Cell-cell contact during gamma irradiation is not required to induce a bystander effect in normal human keratinocytes: evidence for release during irradiation of a signal controlling survival into the medium. , 1998, Radiation research.

[12]  A. Levine,et al.  The p53 functional circuit. , 2001, Journal of cell science.

[13]  A. Levine,et al.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. , 1994, Genes & development.

[14]  Edouard I Azzam,et al.  Oxidative metabolism modulates signal transduction and micronucleus formation in bystander cells from alpha-particle-irradiated normal human fibroblast cultures. , 2002, Cancer research.

[15]  J. Slot,et al.  Proteomic and Biochemical Analyses of Human B Cell-derived Exosomes , 2003, The Journal of Biological Chemistry.

[16]  J. Little,et al.  Bystander effects: intercellular transmission of radiation damage signals. , 2002, Radiation protection dosimetry.

[17]  B. Kennedy,et al.  NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.

[18]  M. Hendrix,et al.  Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Brunak,et al.  Improved prediction of signal peptides: SignalP 3.0. , 2004, Journal of molecular biology.

[20]  J. Minna,et al.  Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. , 1986, Cancer research.

[21]  C. Mothersill,et al.  Production of a signal by irradiated cells which leads to a response in unirradiated cells characteristic of initiation of apoptosis , 2000, British Journal of Cancer.

[22]  P. Ricciardi-Castagnoli,et al.  Proteomic Analysis of Dendritic Cell-Derived Exosomes: A Secreted Subcellular Compartment Distinct from Apoptotic Vesicles1 , 2001, The Journal of Immunology.

[23]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[24]  P. Selby,et al.  Proteomic analysis of melanoma‐derived exosomes by two‐dimensional polyacrylamide gel electrophoresis and mass spectrometry , 2004, Proteomics.

[25]  Graça Raposo,et al.  The Biogenesis and Functions of Exosomes , 2002, Traffic.

[26]  H. Hoogsteden,et al.  Proteomic analysis of exosomes secreted by human mesothelioma cells. , 2004, The American journal of pathology.

[27]  H. Geuze,et al.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. , 2000, Journal of cell science.

[28]  L. Donehower,et al.  In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. , 1993, Oncogene.

[29]  F. Kittrell,et al.  Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. , 2001, Cancer research.

[30]  J. R. Erickson,et al.  Maspin Is an Intracellular Serpin That Partitions into Secretory Vesicles and Is Present at the Cell Surface , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  D. Notterman,et al.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. , 2000, Genes & development.

[32]  Andrew R. Snyder Review of radiation-induced bystander effects , 2004, Human & experimental toxicology.

[33]  G. Raposo,et al.  Exosomes: endosomal-derived vesicles shipping extracellular messages. , 2004, Current opinion in cell biology.

[34]  H. Geuze,et al.  Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes* , 1998, The Journal of Biological Chemistry.

[35]  B. Lehnert,et al.  Radiation-induced effects in unirradiated cells: a review and implications in cancer. , 2002, International journal of oncology.

[36]  E. Feinstein,et al.  Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53 , 1998, Oncogene.

[37]  Y. Matsui,et al.  Effects of p53 Mutations on Cellular Sensitivity to Ionizing Radiation , 2001, American journal of clinical oncology.

[38]  和久 利彦 Contribution of CD95 Ligand-Induced Neutrophil Infiltration to the Bystander Effect in p53 Gene Therapy for Human Cancer , 2001 .

[39]  E. Skrzypczak‐Jankun,et al.  Plasminogen activator inhibitor type-1: its structure, biological activity and role in tumorigenesis (Review). , 2004, International Journal of Molecular Medicine.

[40]  Laurence Zitvogel,et al.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming , 2001, Nature Medicine.

[41]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[42]  M. Hendrix,et al.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.

[43]  J. Dausset,et al.  The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Y. Nakamura,et al.  Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  L. Zitvogel,et al.  Malignant effusions and immunogenic tumour-derived exosomes , 2002, The Lancet.